Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02772718 · ClinicalTrials.gov registry record · Phase 2
An Open-Label Study of XOMA 358 in Patients With Hypoglycemia After Gastric Bypass Surgery
A Phase 2 study, sponsored by Xoma (US).
- Completed
- Registry status
- Phase 2
- Development phase
- 20
- Enrollment target
NCT02772718: Completed Phase 2 study, sponsored by Xoma (US).
NCT02772718 is a Phase 2 study that has completed, run by Xoma (US). The registered enrollment target is 20 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02772718, a Phase 2 study, has completed, sponsored by Xoma (US).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and clinical pharmacology of XOMA 358 in patients with hypoglycemia after gastric bypass surgery.
Primary Outcome
Safety assessed by treatment-emergent adverse events
Interventions
- DRUG XOMA 358 single dose level A
- DRUG XOMA 358 single dose level B
- DRUG XOMA 358 single dose level C
- DRUG XOMA 358 multiple dose level 1
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2016-04 |
| Est. Completion | 2021-05 |
| Phase | Phase 2 |
What the finished NCT02772718 record still lists
NCT02772718 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (85% lower).
The record links to 0 conditions, and to 4 interventions - of which XOMA 358 single dose level A is the first listed.
NCT02772718 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02772718 about?
NCT02772718 is a clinical study titled "An Open-Label Study of XOMA 358 in Patients With Hypoglycemia After Gastric Bypass Surgery". The purpose of this study is to evaluate the safety and clinical pharmacology of XOMA 358 in patients with hypoglycemia after gastric bypass surgery.
What is the current status of trial NCT02772718?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2016-04. Estimated completion is 2021-05.
What interventions are being tested in trial NCT02772718?
The interventions under investigation include: XOMA 358 single dose level A (DRUG), XOMA 358 single dose level B (DRUG), XOMA 358 single dose level C (DRUG), XOMA 358 multiple dose level 1 (DRUG).
Who is sponsoring clinical trial NCT02772718?
This trial is sponsored by Xoma (US), which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02772718's enrollment target sits among peer trials
20 1805th of 2000 higher than 107 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia